Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease.
Neuropharmacology
; 110(Pt A): 519-529, 2016 11.
Article
em En
| MEDLINE
| ID: mdl-26976670
Palavras-chave
10252734); 108223); 11507802); 2-Arachidonoylglycerol (PubChem CID; 2-Deoxy-d-glucose (PubChem CID; 25021165); 3177); 4302963); 439501); 5281969); 5282280); 5311006); 5311501); 6918505); AM630 (PubChem CID; Anandamide (AEA); Anandamide (PubChem CID; Arachidonyl-2-chloroethylamide (PubChem CID; Cannabinoid CB(2) receptor; Cerebral glucose uptake; Cyclooxygenase-2 (COX-2); DuP697 (PubChem CID; GP1a (PubChem CID; JWH133 (PubChem CID; JZL184 (PubChem CID; LY2183240 (PubChem CID; Ouabain (PubChem CID; Positron emission tomography (PET); WIN55212-2 (PubChem CID; WWL70 (PubChem CID:17759121); ß-amyloid
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Encéfalo
/
Receptor CB2 de Canabinoide
/
Doença de Alzheimer
/
Glucose
Limite:
Animals
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article